| 영문 | poliovirus | 한글 | 폴리오바이러스 |
|---|---|---|---|
| 설명 | 피코루나바이러스과, 엔테로바이러스속의 바이러스이며, 회색척수염(소아마비)의 병원체이다. 1, 2, 3형의 혈청형으로 분류한다. 1형이 전마비성 회백수염의 85%를 차지한다. 외피를 갖지 않는 정이십면체, 직경 25~30μm 이다. 경구적으로 침입한 후 인두와 작은창자에 감염하며, 주로 림프조직(특히 편도와 장관의 집합림프소포)에서 증식하여, 바이러스혈증을 일으키며 전신으로 퍼진다. 감염자의 대부분은 비교적 경증(99%는 불현성 감염)으로 끝나지만, 드물게 바이러스가 혈류를 매체로 뇌의 운동겉질과 척수의 앞뿔세포에 도달하면 마비증상이 나타난다. 마비를 나타내는 증례로는 근육통, 근육강직 등 전구증상이 나오고 즉시 이완성 마비가 나타난다. |
||
| MOPV | monovalent oral poliovirus vaccine |
|---|---|
| PVR | peripheral vascular resistance; perspective volume rendering; poliovirus receptor; postvoiding resid... |
| PVS | percussion, vibration, suction; persistent vegetative state; persistent viral syndrome; Plummer-Vins... |
| IPV | Inactivated poliovirus vaccine |
|---|---|
| OPV | Oral Poliovirus Vaccine |
| PV | Poliovirus |
| PVR | Poliovirus receptor |
| PV1 | Poliovirus type 1 |
| poliovirus vaccines | Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine. See: Salk vaccine. (05 Mar 2000) |
|---|
| poliovirus | <virology> A member of the enterovirus group of Picornaviridae that causes poliomyelitis. (18 Nov 1997) |
|---|---|
| poliovirus hominis | The picornavirus (genus Enterovirus) causing poliomyelitis in humans; the route of infection is the alimentary tract, but the virus may enter the bloodstream and nervous system, sometimes causing paralysis of the limbs and, rarely, encephalitis; many infections are inapparent; serologic types 1, 2, and 3 are recognised, type 1 being responsible for most paralytic poliomyelitis and most epidemics. Synonym: poliovirus hominis, poliovirus. (05 Mar 2000) |
| poliovirus vaccine | A suspension of formalin-inactivated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used in the united states only for immunization of immunologically deficient patients and for primary immunization of unimmunised adults at risk. (12 Dec 1998) |
| poliovirus vaccine, oral | A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (12 Dec 1998) |
| inactivated poliovirus vaccine | Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine. See: Salk vaccine. (05 Mar 2000) |
| oral poliovirus vaccine | An aqueous suspension of live, attenuated strains of poliomyelitis virus (types 1, 2, and 3) given orally for active immunization against poliomyelitis. See: Sabin vaccine. Synonym: poliomyelitis vaccines. (05 Mar 2000) |
| live oral poliovirus vaccine | Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine. See: Salk vaccine. (05 Mar 2000) |
| aids vaccines | Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent aids. Some vaccines containing antigens are recombinantly produced. (12 Dec 1998) |
| bacterial vaccines | Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. (12 Dec 1998) |
| cancer vaccines | Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumour cells as the source of antigens, or using tumour-specific antigens, often recombinantly produced. (12 Dec 1998) |
| vaccines | Vaccines are microbial preparations of killed or modified microorganisms which can stimulate an immune response in the body in order to prevent future infection with similar microorganism. The smallpox vaccine has totally eliminated the smallpox disease from our planet. (12 Dec 1998) |
| vaccines, attenuated | Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. (12 Dec 1998) |
| vaccines, combined | Two or more vaccines in a single dosage form. (12 Dec 1998) |
| vaccines, conjugate | Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognised by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection. (12 Dec 1998) |
| vaccines, DNA | Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers. (12 Dec 1998) |
Synonyms : Vaccines, Poliovirus
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|